Characteristic | Â |
---|---|
Age, yr | 57.7 ± 7.7 |
Male, No. (%) | 10 (90.9) |
Alanine aminotransferase, U/L a | 36.18 ± 17.8 |
Aspartate aminotransferase, U/L b | 39.09 ± 17.0 |
Total bilirubin, mg/dL | 0.88 ± 0.47 |
Albumin, g/dL c | 3.91 ± 0.57 |
γ-glutamyltransferase, U/L | 93.9 ± 83.56 |
Prothombin time, INR e | 1.13 ± 0.14 |
Platelet count, per mm 3 | 153,81 ± 93,73 |
α-fetoprotein, ng/mL d |  |
 Normal, No. | 8 |
 Abnormal, No. | 2 |
Non-tumorous tissue | Â |
 Activity Grade | 5.75 ± 3.06 |
 Fibrosis Stage | 5.1 ± 1.56 |
 F5/F6, No. | 9 |
Tumor Gradef | |
 G2, No. | 7 |
 G3, No. | 3 |
 G4, No. | 1 |
Tumor size | Â |
 ≥2 cm, No. | 4 |
 ≥2 and ≤ 3 cm, No. | 4 |
 >3 cm, No. | 3 |
HBsAg-positive, No. | 11 |
HBeAg-positive, No. | 0 |
Anti-HBc, No. | 11 |
Anti-HBe, No. | 11 |
IgG anti-HDAg positive, No. | 1 |
IgM anti-HDAg, No. | 0 |
Serum HDV RNA positive, No. | 0 |
Anti-HCV positive, No. | 1 |
Serum HCV RNA positive, No. | 0 |